Back
iShares Russell Top 200 Growth Index Fund Vs. Novo Nordisk AS Industry Stock Comparison
Sell
37
IWY
iShares Russell Top 200 Growth Index Fund
Last Price:
$233.55
Seasonality Move:
4.28%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$86.80
Seasonality Move:
9.09%
Sell
37
iShares Russell Top 200 Growth Index Fund (IWY)
is a Sell
Is iShares Russell Top 200 Growth Index Fund a Buy, Sell or Hold?
-
The current iShares Russell Top 200 Growth Index Fund [IWY] share price is $236.49. The Score for IWY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
IWY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $85.04. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
IWY Stock Price Chart
What is iShares Russell Top 200 Growth Index Fund's stock price today?
-
The iShares Russell Top 200 Growth Index Fund share price today is $236.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IWY is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
IWY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 49.18 | Sell |
Chaikin Money Flow: | 239669 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (235.58 - 242.02) | Sell |
Bollinger Bands (100): | (214.62 - 235.1) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.19 | Sell |
Relative Strength Index (14 RSI): | 32.42 | Sell |
Chaikin Money Flow: | -1041 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.31 - 109.25) | Sell |
Bollinger Bands (100): | (99.35 - 129.37) | Sell |
IWY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 237.28 | Sell |
20-day SMA: | 239.29 | Sell |
50-day SMA: | 233.13 | Buy |
200-day SMA: | 213.95 | Buy |
8-day EMA: | 237.67 | Sell |
20-day EMA: | 237.59 | Sell |
50-day EMA: | 233.35 | Buy |
200-day EMA: | 214.49 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.85 | Sell |
20-day SMA: | 94.98 | Sell |
50-day SMA: | 102.41 | Sell |
200-day SMA: | 123.63 | Sell |
8-day EMA: | 86.44 | Sell |
20-day EMA: | 92.43 | Sell |
50-day EMA: | 101.51 | Sell |
200-day EMA: | 114.69 | Sell |
iShares Russell Top 200 Growth Index Fund Earnings Growth & IWY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
iShares Russell Top 200 Growth Index Fund Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |